Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration

Ann Rheum Dis. 2016 Jul;75(7):e37. doi: 10.1136/annrheumdis-2016-209502. Epub 2016 Mar 31.
No abstract available

Keywords: Anti-TNF; DMARDs (biologic); Rheumatoid Arthritis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Biosimilar Pharmaceuticals*
  • Etanercept*
  • Receptors, Tumor Necrosis Factor

Substances

  • Antirheumatic Agents
  • Biosimilar Pharmaceuticals
  • Receptors, Tumor Necrosis Factor
  • Etanercept